Abstract
The authors proposed the use of thymopentin, a new immunomodulating drug, for the treatment of herpes zoster. The observations in 53 subjects treated with thymopentin and 90 patients treated with traditional therapy highlighted the ability of the drug to reduce the duration of the disease and scabbing time. The early start of therapy produced a notable reduction of the pain characteristic of herpes zoster. On the basis of their observations, the authors assumed that thymopentin possesses an antiphlogistic activity.
| Original language | English |
|---|---|
| Pages (from-to) | 672-678 |
| Number of pages | 7 |
| Journal | Current Therapeutic Research |
| Volume | 44 |
| Issue number | 4 |
| Publication status | Published - 1988 |
Fingerprint
ASJC Scopus subject areas
- Medicine(all)
Cite this
Thymopentin in the treatment of herpes zoster. / Lomuto, M.; Zenarola, P.; Ditano, G.; Cascavilla, N.
In: Current Therapeutic Research, Vol. 44, No. 4, 1988, p. 672-678.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Thymopentin in the treatment of herpes zoster
AU - Lomuto, M.
AU - Zenarola, P.
AU - Ditano, G.
AU - Cascavilla, N.
PY - 1988
Y1 - 1988
N2 - The authors proposed the use of thymopentin, a new immunomodulating drug, for the treatment of herpes zoster. The observations in 53 subjects treated with thymopentin and 90 patients treated with traditional therapy highlighted the ability of the drug to reduce the duration of the disease and scabbing time. The early start of therapy produced a notable reduction of the pain characteristic of herpes zoster. On the basis of their observations, the authors assumed that thymopentin possesses an antiphlogistic activity.
AB - The authors proposed the use of thymopentin, a new immunomodulating drug, for the treatment of herpes zoster. The observations in 53 subjects treated with thymopentin and 90 patients treated with traditional therapy highlighted the ability of the drug to reduce the duration of the disease and scabbing time. The early start of therapy produced a notable reduction of the pain characteristic of herpes zoster. On the basis of their observations, the authors assumed that thymopentin possesses an antiphlogistic activity.
UR - http://www.scopus.com/inward/record.url?scp=0023699907&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0023699907&partnerID=8YFLogxK
M3 - Article
AN - SCOPUS:0023699907
VL - 44
SP - 672
EP - 678
JO - Current Therapeutic Research - Clinical and Experimental
JF - Current Therapeutic Research - Clinical and Experimental
SN - 0011-393X
IS - 4
ER -